Account
K2 Communications wins the PR and Social Media mandate of Zeno Health
Mumbai: Zeno Health, an omnichannel platform for quality and affordable generic medicines, has appointed K2 Communications Pvt. Ltd. as its integrated communication partner. The legacy firm has been instrumental in announcing the brand’s successful securement of $25 million in Series C funding last month.
Commenting on the partnership, Zeno Health head of growth Kush Jain stated, “Zeno Health has been in search of a trusted partner with a proven track record in our niche to initiate our communication journey. K2 Communications is renowned and respected for its innovative and out-of-the-box ideas. They also have a dedicated vertical team for the healthcare sector and this works in our favour. Moreover, the healthcare sector, and especially the pharmaceutical market in India, is poised for a revolution in the coming years. We believe this is the opportune moment to accelerate our efforts in educating the masses about generic medicine. K2’s approach aligns with our objectives, and we are delighted to have them on board. We are confident that our shared vision of democratising healthcare in India will soon become a reality.”
In this new collaboration, K2 Communications will collaborate closely with Zeno Health’s corporate communications and marketing team to implement comprehensive strategies aimed at enhancing the company’s brand positioning within the healthcare and pharmaceutical sectors in India.
K2 Communications founder and CEO Shiv Shankar Devaraaj commented, “While K2 Communications caters to various segments, it also specializes in healthcare and its ancillary sectors. In addition, we have a fully functional and adept Mumbai branch to cater to clients in the region. We have a legacy of 21 years and most of our clients have been with us since the beginning. We are grateful to Siddharth Gadia, CEO and Co-Founder and Mr. Girish Agrawal, Founder of Zeno Health for reposing their faith in us. We are committed to seeing them achieve their goals using grounded PR narratives that will sync with the pulse of all stakeholders.”
Account
BigTrunk Communications wins digital mandate for Soframycin
MUMBAI: BigTrunk Communications, an integrated digital marketing agency known for driving brand transformations across industries, has been awarded the digital marketing mandate for Soframycin, one of India’s most trusted antiseptic cream brands from the EncubeEthicals portfolio. With this collaboration, Soframycin makes its debut into the digital space, aiming to amplify its presence across India through compelling social media narratives and data-led campaigns. BigTrunk will lead the brand’s digital strategy and execution, with a focus on connecting Soframycin’s legacy of trust with today’s health-conscious and digitally engaged audience.
Soframycin has been a household name for generations, widely recognized for its efficacy in treating cuts, burns, and wounds. Backed by the scientific rigor and pharmaceutical expertise of EncubeEthicals, a pharmaceutical powerhouse since 1998, the brand benefits from the expertise of over 1,400 professionals, including more than 200 R&D specialists and a robust team of quality experts. With a presence in over 50 countries, Encube’s commitment to excellence in topical formulations adds deep credibility to Soframycin’s legacy. Now, as the brand enters the digital space, BigTrunk Communications will lead the charge in reimagining Soframycin’s story—creating modern, relatable digital experiences that stay true to its heritage.
“As we take Soframycin into its next chapter of growth, embracing digital media is not just a strategy but a necessity. We wanted a partner who could translate our scientific credibility into engaging, relatable content for today’s audience,” said Soframycin vice president – marketing, Ajay Rawal. “BigTrunk’s deep understanding of healthcare communications and digital behavior makes them the ideal partner to build meaningful narratives around wound care, trust, and wellbeing.”
“Soframycin is more than a product—it’s a legacy deeply rooted in care and science,” added BigTrunk Communications founder & managing director Bharat Subramaniam. “We’re excited to take on this responsibility of guiding a heritage brand into the digital world. Our focus will be on creating contextual storytelling and purpose-driven campaigns that bring Soframycin closer to Indian families, both old and new.”








